Open heart surgery in patients with end-stage renal failure: fifteen-year experience

Ilknur Bahar1, Ahmet Akgul, Ali E Demirbag

  • 1Department of Cardiovascular Surgery, Türkiye Yuksek Ihtisas Hospital, Ankara, Turkey.

Journal of Cardiac Surgery
|September 10, 2008
PubMed

Insights

Cardiac surgery in patients requiring hemodialysis presents increased risks but is feasible. An effective hemodialysis program can lead to acceptable outcomes and mortality rates in these complex cases.

Area of Science:

  • Cardiology
  • Nephrology
  • Cardiac Surgery

Background:

  • Patients with end-stage renal failure requiring hemodialysis represent a growing population undergoing cardiac surgery.
  • Assessing the risks and outcomes of cardiopulmonary bypass (CPB) in this specific patient group is crucial for surgical planning and patient management.

Purpose of the Study:

  • To evaluate the risk factors and outcomes of cardiac surgery utilizing cardiopulmonary bypass (CPB) in patients dependent on hemodialysis.
  • To compare the perioperative findings and survival rates between hemodialysis-dependent patients and those with normal renal function.

Main Methods:

  • A retrospective analysis of 16,425 patients undergoing open heart surgery with CPB between 1991 and 2006.
  • Identification of 91 patients (0.6%) with hemodialysis-dependent end-stage renal failure (HDRF group) and comparison with a control group of patients with normal renal function.
  • Evaluation of preoperative, operative, and postoperative data, including survival analyses for the HDRF group.

Main Results:

  • The HDRF group underwent various cardiac procedures, including coronary artery, valve, and aortic surgeries.
  • Cardiopulmonary bypass and aortic cross-clamping times were significantly longer in the HDRF group.
  • While early mortality was slightly higher in the HDRF group (7.7% vs. 4.8%), there were no significant differences in reoperations, infections, or major systemic complications. Actuarial survival rates at 1, 5, and 10 years were 86%, 20%, and 6.8% respectively for HDRF survivors.

Conclusions:

  • Open heart surgery in hemodialysis patients is associated with increased risks.
  • However, with an effective hemodialysis program, these patients can undergo surgery with acceptable operative complications and mortality.
  • This study highlights the feasibility of cardiac surgery in end-stage renal failure patients when managed appropriately.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...